menu
    • menu

    Company profile for Marengo Therapeutics

    NEW Drugs in Dev: 2
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Marengo Therapeutics is pioneering a new way to activate the body’s own immune system to mount a rapid, effective, and durable response against cancer. Our unique therapeutic platform selectively boosts T cells, turbocharging potent anti-tumor activity and promoting long-term immunity to keep cancer at bay. Activating the right immune response to promote lifelong protection against cancer.To create a world in which everyone...
    Marengo Therapeutics is pioneering a new way to activate the body’s own immune system to mount a rapid, effective, and durable response against cancer. Our unique therapeutic platform selectively boosts T cells, turbocharging potent anti-tumor activity and promoting long-term immunity to keep cancer at bay. Activating the right immune response to promote lifelong protection against cancer.To create a world in which everyone’s immune system can defeat cancer. Marengo’s lead project, a first- and -best-in-class therapy with single agent potential, is progressing to IND for several solid tumors with high-unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Marengo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    840 Memorial Drive, 4th Floor, Cambridge, MA 02139
    Telephone
    Telephone
    (617) 917-4980
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://marengotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/marengo-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/marengotx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Marengo Reports Phase 2 Invikafusp Data, STAR Program at AACR
    Marengo Reports Phase 2 Invikafusp Data, STAR Program at AACR

    17 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/marengo-reports-late-breaking-initial-phase-2-clinical-results-from-invikafusp-alfa-plus-trodelvy-and-unveils-partnered-novel-ipn01203star0501-star-program-in-phase-1-at-aacr-2026-302745374.html

    PR NEWSWIRE
    17 Apr 2026
    Share Share
    Marengo To Unveil Start-002 Study Results At 2025 Breast Cancer
    Marengo To Unveil Start-002 Study Results At 2025 Breast Cancer

    12 Dec 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/marengo-to-present-initial-results-from-invikafusp-alfa-and-trodelvy-combination-study-start-002-at-the-2025-san-antonio-breast-cancer-symposium-302639926.html

    PR NEWSWIRE BIO
    12 Dec 2025
    Share Share
    Marengo Invikafusp Alfa Shows Pan Tumor Activity In Ph2 Trial
    Marengo Invikafusp Alfa Shows Pan Tumor Activity In Ph2 Trial

    07 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/marengo-late-breaking-oral-presentation-highlights-single-agent-pan-tumor-activity-of-invikafusp-alfa-across-pd-1-resistant-cancers-in-phase-2-clinical-trial-at-sitc-2025-302607991.html

    PR NEWSWIRE
    07 Nov 2025
    Share Share
    Marengo To Unveil Invikafusp Alfa Monotherapy Data at SITC 2025
    Marengo To Unveil Invikafusp Alfa Monotherapy Data at SITC 2025

    31 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/marengo-to-present-late-breaking-clinical-oral-abstract-at-sitc-2025-highlighting-initial-monotherapy-activity-of-invikafusp-alfa-in-tissue-agnostic-tmb-high-advanced-cancers-302600621.html

    PR NEWSWIRE
    31 Oct 2025
    Share Share
    Marengo’s Ph2 Data Show Invikafusp Alfa Activity at ESMO
    Marengo’s Ph2 Data Show Invikafusp Alfa Activity at ESMO

    17 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/marengo-presents-initial-phase-2-results-demonstrating-broad-single-agent-activity-of-invikafusp-alfa-across-multiple-pd-1-refractory-or--resistant-solid-tumors-as-a-late-breaking-oral-presentation-at-esmo-2025-302587142.html

    PR NEWSWIRE
    17 Oct 2025
    Share Share
    Marengo To Unveil Late-Breaking ESMO 2025 Abstract On Invikafusp
    Marengo To Unveil Late-Breaking ESMO 2025 Abstract On Invikafusp

    24 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/marengo-to-present-a-late-breaking-clinical-oral-abstract-at-esmo-2025-on-initial-phase-2-clinical-data-of-invikafusp-monotherapy-activity-in-patients-with-antigen-rich-solid-tumors-resistant-to-immune-checkpoint-blockade-302565714.html

    PR NEWSWIRE
    24 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search